SYPHU-China

October 21, 2023

SYPHU-China # HER2-Positive Tumor Stalker # In 2023, SYPHU-China focuses on targeted therapy for HER2-positive solid tumors. Protein engineering techniques were used to construct chemoreceptor eTlpC that can target tumor microenvironments with high lactate concentration, and ADC(Antibody-drug conjugate) drugs were used as a means to attack tumors. A synthetic biology approach was utilized to ensure the safety of LBP(Live Biotherapeutic Products) drugs using gene circuits to construct population sensing modules and suicide switch modules. ...